// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Correlation of Initial Echocardiographic Parameters and Emergency Room Admission Rates in Heart Failure Clinic Patients

X. Cai - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Tricuspid regurgitation

EF-40

Physician Prediction versus Model Predicted Prognosis in Ambulatory Patients with Heart Failure

T.A. Buchan - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Directly to a DOAC? Safety of Alternatives to Warfarin for Anticoagulation in Heart Transplantation

M. Tremblay-Gravel - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Warfarin

Gender Differences in Pre-Transplant Characteristics and Short-Term Clinical Outcomes Post Heart Transplantation

A. Almufleh - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acute Rejection (AR) and Lymphocytic Bronchiolitis (LB) in a Multicenter Lung Transplant Cohort

J.L. Todd - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Transplant rejection

N/A

Evaluating Novel Graft Failure Thresholds after Lung Transplantation

J. Liu - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Quantitative CT Imaging Analysis for Chronic Lung Allograft Dysfunction in Single Lung Transplant Recipients

M. Horie - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pre-Transplant Opioid Use is Not Associated with Overall Graft Survival in Lung Transplant Recipients

S. Vahidy - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Morphine

Right Ventricular Dysfunction and Pulmonary Vascular Elastance Coupling in Candidates for Advanced Heart Failure Therapies

S.P. Wright - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Right ventricular dysfunction

N/A

Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular Dysfunction

M.A. McCulloch - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Left ventricular dysfunction

N/A

Electrocardiographic Trends in Boys with Duchenne Muscular Dystrophy

K. Gambetta - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Duchenne muscular dystrophy

N/A

Pediatric Hypertrophic Cardiomyopathy: Survival and Prognostic Indicators in the Current Era

J. Ashkanase - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Utilization of Heart Failure Medications in Duchenne Muscular Dystrophy Patients with Left Ventricular Systolic Dysfunction

A.K. Lal - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Duchenne muscular dystrophy

N/A

The Role of Prophylactic Heart Failure Therapy in Duchenne Muscular Dystrophy

A.K. Lal - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Duchenne muscular dystrophy

EF-40

Outcomes in Pediatric Hypertrophic Cardiomyopathy Patients with Reduced Systolic Ventricular Function

J. Ashkanase - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Physical Activity, Exercise Capacity and Quality of Life in Adolescent Heart Transplant Patients

N. Arora - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ABO Incompatible Heart Transplantation in Young Children: Less Rejection and Infection

S. Urschel - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

End Stage Liver Disease Models and Outcomes in Pediatric Patients Supported with Short-Term Continuous Flow Ventricular Assist Devices

G. Malik - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

End-stage liver disease

N/A

Readmission to the Pediatric Cardiac Intensive Care Unit in Pediatric Patients with Durable Ventricular Assist Devices

J.J. Chacko - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Right Ventricular - Pulmonary Vascular Coupling at Rest and Exercise in Patients with Dyspnea and/or Suspected Pulmonary Hypertension

S.P. Wright - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Copyright © 2026. QuantiNova All rights reserved